2021 annual financial data
ImmuCell 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was 4.96%.
Operating income was 257,385 USD and net income was -78,292 USD.
Operating cash flow was 954,170 USD.
Get free ImmuCell email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 19,242,969 USD
- Operating income
- 257,385 USD
- Net income
- -78,292 USD
- Operating cash flow
- 954,170 USD